Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Whaley-Connell

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
American Journal of Nephrology|December 16, 2006
Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonismAmit Rai, Adam Whaley-Connell, Samy McFarlane, et al.
Cardiorenal Medicine|January 20, 2012
Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN StudyAdam Whaley-Connell, Das Purkayastha, Anthony Yadao, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 17, 2009
Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney diseaseRavi Nistala, Yongzhong Wei, James R Sowers, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2005
Hypertension and the cardiometabolic syndromeCamila Manrique, Guido Lastra, Adam Whaley-Connell, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2010
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular diseaseJun Ren, Lakshmi Pulakat, Adam Whaley-Connell, et al.
Current Opinion in Pharmacology|January 22, 2013
Therapy of obese patients with cardiovascular diseaseAnkur Jindal, Adam Whaley-Connell, Stephen Brietzke, et al.
Current Hypertension Reports|July 6, 2018
Arterial Stiffness in Hypertension: an UpdateKorshie Dumor, Michael Shoemaker-Moyle, Ravi Nistala, et al.
Current Diabetes Reports|July 16, 2008
Antihypertensive medications and their effects on lipid metabolismMrunalini Deshmukh, Ho Won Lee, Samy I McFarlane, et al.
Journal of Clinical Lipidology|February 5, 2011
Chronic kidney disease as a cardiovascular risk state and considerations for the use of statinsPeter A McCullough, Leslie R Rocher, Ravi Nistala, et al.
Cardiorenal Medicine|January 20, 2012
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyLakshmi Pulakat, Vincent G DeMarco, Adam Whaley-Connell, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
American Journal of Nephrology|December 16, 2006
Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonismAmit Rai, Adam Whaley-Connell, Samy McFarlane, et al.
Cardiorenal Medicine|January 20, 2012
Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN StudyAdam Whaley-Connell, Das Purkayastha, Anthony Yadao, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 17, 2009
Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney diseaseRavi Nistala, Yongzhong Wei, James R Sowers, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2005
Hypertension and the cardiometabolic syndromeCamila Manrique, Guido Lastra, Adam Whaley-Connell, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2010
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular diseaseJun Ren, Lakshmi Pulakat, Adam Whaley-Connell, et al.
Current Opinion in Pharmacology|January 22, 2013
Therapy of obese patients with cardiovascular diseaseAnkur Jindal, Adam Whaley-Connell, Stephen Brietzke, et al.
Current Hypertension Reports|July 6, 2018
Arterial Stiffness in Hypertension: an UpdateKorshie Dumor, Michael Shoemaker-Moyle, Ravi Nistala, et al.
Current Diabetes Reports|July 16, 2008
Antihypertensive medications and their effects on lipid metabolismMrunalini Deshmukh, Ho Won Lee, Samy I McFarlane, et al.
Journal of Clinical Lipidology|February 5, 2011
Chronic kidney disease as a cardiovascular risk state and considerations for the use of statinsPeter A McCullough, Leslie R Rocher, Ravi Nistala, et al.
Cardiorenal Medicine|January 20, 2012
The Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyLakshmi Pulakat, Vincent G DeMarco, Adam Whaley-Connell, et al.
Pageof 17